Hög risk att insjukna i tyreotoxikos i norra sverige: Retrospektiv genomgång av journaler i norrbotten för åren 2004-2005

Lakartidningen

Volumn 105, Issue 45, 2008, Pages 3196-3201

  Westerlund, Ellen ^a,c   Eliasson, Mats ^a,b  

^a UMEÅ UNIVERSITY   (Sweden)

^b SUNDERBY HOSPITAL   (Sweden)

^c Sunderby Sjukhus ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNE THYROIDITIS; CLASSIFICATION; FEMALE; GRAVES DISEASE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; NODULAR GOITER; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; SWEDEN; THYROTOXICOSIS;

ADULT; AGED; FEMALE; GOITER, NODULAR; GRAVES DISEASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SWEDEN; THYROIDITIS, AUTOIMMUNE; THYROTOXICOSIS;

EID: 56649099087     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Berglund J, Christensen SB, Hallengren B. Total and age-specific incidence of Graves' thyrotoxicosis, toxic nodular goitre and solitary toxic adenoma in Malmo 1970-74. J Intern Med. 1990;227:137-41.
2. Berglund J, Ericsson UB, Hallengren B. Increased incidence of thyrotoxicosis in Malmo during the years 1988-1990 as compared to the years 1970-1974. J Intern Med. 1996;239:57-62.
3. Lundgren E, Borup Christensen S. Decreasing incidence of thyrotoxicosis in an endemic goitre inland area of Sweden. Clin Endocrinol (Oxf ). 1990;33:133-8.
4. Laurberg P, Pedersen KM, Vestergaard H, Sigurdsson G. High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. J Intern Med. 1991;229:415-20.
5. Brownlie BE, Wells JE. The epidemiology of thyrotoxicosis in New Zealand: incidence and geographical distribution in north Canterbury, 1983-1985. Clin Endocrinol (Oxf ). 1990;33:249-59.
6. Flynn RW, MacDonald TM, Morris AD, Jung RT, Leese GP. The thyroid epidemiology, audit, and research study: thyroid dysfunction in the general population. J Clin Endocrinol Metab. 2004;89:3879-84.
7. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whick ham Survey. Clin Endocrinol (Oxf). 1995;43:55-68.
8. Serdiuk SE, Bakalov SA, Golitsyn SP, Molashenko NV, Platonova NM, Sviridenko NIu. [Incidence and predictors of thyroid dysfunction caused by long-term intake of amiodaron]. Ter Arkh. 2005;77:33-9.
9. Bogazzi F, Bartalena L, Scarcello G, Campomori A, Rossi G, Martino E. The age of patients with thyrotoxicosis factitia in Italy from 1973 to 1996. J Endocrinol Invest. 1999;22:128-33.
10. Wood DF, Zalin AM, Ratcliffe WA, Sheppard MC. Elevation of free thyroxine measurements in patients without thyrotoxicosis. Q J Med. 1987;65:863-70.
11. Mandac JC, Chaudhry S, Sherman KE, Tomer Y. The clinical and physiological spectrum of interferonalpha induced thyroiditis: toward a new classification. Hepatology. 2006;43:661-72.
12. Vestergaard P. Smoking and thyroid disorders - a meta-analysis. Eur J Endocrinol. 2002;146:153-61.
13. Stegmayr B, Eliasson M, Rodu B. The decline of smoking in northern Sweden. Scand J Public Health. 2005;33:321-4; 243.